Czechia – Absorbable haemostatics – Krytí hemostatické na bázi oxidované neregenerované celulózy
Fakultní nemocnice Olomouc
Buyer country
Czechia
Publication date
Not specified
Biderra sector
Health and medical
Data source
TED open data
Decision signals
First-pass opportunity review
These signals are calculated from the indexed fields. They help prioritize a review but do not replace eligibility checks in the official procurement documents.
- Timing signal
- Deadline not indexed
- Indexed data completeness
- 86%
- Official title coverage
- 7 languages
- Classification signal
- 33141127
Check the official notice
Based on seven decision fields
Preserved from source-supplied versions
Medical equipment, pharmaceuticals and personal care products
Official title versions
TED may publish the same notice title in several official languages. Biderra preserves the versions supplied in the source feed.
Chequia – Hemostáticos absorbibles – Krytí hemostatické na bázi oxidované neregenerované celulózy
Tsjechië – Resorbeerbare hemostatica – Krytí hemostatické na bázi oxidované neregenerované celulózy
Czechy – Hemostatyki wchłanialne – Krytí hemostatické na bázi oxidované neregenerované celulózy
Tchéquie – Hémostatiques résorbables – Krytí hemostatické na bázi oxidované neregenerované celulózy
Tschechien – Resorbierbare blutstillende Einlagen – Krytí hemostatické na bázi oxidované neregenerované celulózy
Cechia – Emostatici riassorbibili – Krytí hemostatické na bázi oxidované neregenerované celulózy
Czechia – Absorbable haemostatics – Krytí hemostatické na bázi oxidované neregenerované celulózy
What Biderra adds
For notice 479699-2026, Biderra has normalized the contracting authority country as Czechia, grouped CPV 33141127 under health and medical, compared the available deadline fields with today, measured field completeness, and preserved 7 source-supplied title versions. The official record remains decisive.